Overview
Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation
Status:
Unknown status
Unknown status
Trial end date:
2017-11-01
2017-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study was to evaluate the protective effect of dexmedetomidine on myocardial injury during liver transplantationPhase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Tianjin First Central HospitalTreatments:
Dexmedetomidine
Criteria
Inclusion Criteria:- End stage liver disease scheduled for liver transplantation in Tianjin First Center
Hospital
Exclusion Criteria:
- Pre-existing respiratory failure,renal failure,hepatic encephalopathy